Morinaga&Co (2201) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
15 Oct, 2026Executive summary
FY2023 net sales reached a third consecutive record at ¥213.368bn; operating income rose 33.1% to ¥20.273bn and parent-attributable profit rose 50.6% to ¥15.154bn.
Domestic and U.S. sales growth, along with price revisions, supported profitability despite soaring raw-material costs.
Financial highlights
Gross profit increased 13.1% to ¥86.689bn; SG&A rose 8.1% to ¥66.416bn.
Ordinary income increased 33.5% to ¥21.039bn; net income was ¥15.374bn and parent-attributable profit was ¥15.154bn.
EBITDA was ¥29.7bn, versus ¥25.3bn in FY2022; defined as operating income plus depreciation and amortization.
Operating cash flow was ¥30.174bn, versus an outflow of ¥2.966bn in FY2022; year-end cash and cash equivalents reached ¥47.101bn.
Outlook and guidance
FY2024 forecast: sales ¥222.0bn (+4.0%), operating income ¥20.5bn (+1.1%), ordinary income ¥20.9bn (-0.7%) and parent-attributable profit ¥15.8bn (+4.3%).
Forecast assumes ¥146 per U.S. dollar and incorporates raw-material, energy, FX and logistics headwinds, partly offset by sales growth and price revisions.
FY2026 targets: sales ¥246.0bn, operating income ¥24.6bn, 10.0% operating margin, focused-domain sales ratio of at least 53% and overseas sales ratio of at least 16%.
FY2030 targets: sales of at least ¥300.0bn, operating margin of at least 12%, focused-domain sales ratio of at least 60%, overseas sales ratio of at least 25%, ROE of at least 15% and ROIC of at least 12%.
Latest events from Morinaga&Co
- Q1 earnings rose on U.S. growth and price revisions; FY2024 guidance was unchanged.2201
Q1 2024 - Record first-half sales lifted guidance, while second-half investment is expected to weigh on profit.2201
Q2 2024 - Record 9M sales and higher margins lifted full-year forecasts and the dividend.2201
Q3 2024 - Q1 sales rose 11.4%; a US$136 million U.S. factory will expand HI-CHEW capacity.2201
Q1 2025 - Record H1 sales and higher FY2025 guidance despite cost-pressured operating income.2201
Q2 2025 - 9M sales grew 7.8%, but raw-material inflation pressured earnings; FY2025 forecasts held.2201
Q3 2025 - FY2025 sales hit a record, while cacao inflation and cash outflows tempered gains.2201
Q4 2025 - H1 operating income fell 3.7%, but FY2026 operating-income guidance rose to ¥22.3bn.2201
Q2 2026 - Core sweets growth and MyMo expansion offset by near-term acquisition costs.2201
Q4 2026